Skip to main content

Advertisement

Table 1 Demographic and clinical variables in the study population (n = 226)

From: Evaluation of DNA ploidy in relation with established prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysis

Variable Labels n %
Gender Males 132 61.4
  Females 83 38.6
Age ≤ 60 87 40.5
  60+ 128 59.5
PS ≥ 90 25 11.1
  = 80 75 33.2
  = 70 74 19.5
  = 60 40 17.7
  ≤ 50 42 18.6
Location Head 147 68.4
  Body 52 24.2
  Back ('tail") 16 7.4
Therapy Chemotherapy and surgery 53 24.7
  Chemotherapy only 65 30.2
  Surgery only 24 11.2
  None 73 34.0
Surgery Yes 77 35.8
  No 138 64.2
Chemotherapy Yes 118 54.9
  No 97 45.1
Ploidy < 2.2 20 8.8
  2.2–3.6 86 38.1
  >3.6 120 53.1
Amylase Yes 23 10.7
  No 192 89.3
Grading High 14 6.5
  Medium 187 87.0
  Low 14 6.5
Primary tumor extent 1 15 7.0
  2 60 27.9
  3 77 35.8
  4 63 29.3
CEA ≤ 5 mg/dL 72 33.5
  >5 mg/dL 143 66.5
CA 19-9 ≤ 30 × normal 30 14.0
  >30 × normal 185 86.0
Thrombophlebitis Yes 105 48.8
  No 110 51.2
Diabetes Yes 199 92.6
  No 16 7.4
CRP Normal 150 69.8
  Increased 35 16.3
  Greatly increased 30 14.0
Steatorrhoea Yes 99 46.0
  No 116 54.0
Albumin Yes 114 53.0
  No 101 47.0
Epoetin Yes 36 16.7
  No 179 83.3
Transfusion Yes 61 28.4
  No 154 71.6
Weight loss None 62 28.8
  1–5% 31 14.4
  6–10% 58 27.0
  >10% 64 29.8
Pain None 50 23.3
  Pain 1 84 39.1
  Pain 2 55 25.6
  Pain 3 26 12.1
Metastases None 86 40.0
  LN 37 17.2
  LIV 7 3.3
  AB 29 13.5
  LN-AB 30 14.0
  LIV-LN-AB 26 12.1
Jaundice Yes 46 21.4
  No 169 78.6
  1. AB, abdominal metastasis; CA 19-9, cancer antigen 19-9; CEA, carcinoembryonic antigen; CRP, C-reactive protein; LIV, liver metastasis; LN, lymph node metastasis; 1: tumor < 2 cm confined to the panreas, 2: tumor > 2 cm confined to the pancreas, 3: invasion of adjacent tissues by tumor, 4: invasion of adjacent organs.